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as echocardiography passes its golden anniversary, the
umber and sophistication of the combined echocardio-
raphic techniques continue to grow, as does the ability of
hese techniques to address complex clinical questions,
lucidate mechanisms of disease, and define response to
herapy. This growth occurs in both simplicity and com-
lexity from small, hand-held devices that provide basic
nformation simply and inexpensively to complex, dynamic
hree-dimensional (3D) imaging of regional myocardial
unction. As with other diagnostic techniques, echocardi-
graphy progresses through the: 1) introduction and vali-
ation of new techniques, 2) refinement or extension of
xisting methods, and 3) addition of new information in
reas of particular clinical interest.
HE INTRODUCTION AND
ALIDATION OF NEW TECHNIQUES
he most important new technique to arrive in the last
everal years has been real-time three-dimensional echo-
ardiography (RT3DE). This technique offers several
dvantages over previous 3D methods, because it does
ot require external registration of imaging planes, per-
its shorter scanning time, and can be recorded during a
ingle breath hold. Because images are often assembled
ver four cardiac cycles, it is not technically a real-time
ethod but still provides important dynamic 3D cardiac
ata. Studies are now appearing that validate the accuracy
f RT3DE in assessing cardiac structure and function.
eft ventricular (LV) volumes, mass, and ejection frac-
ion (EF). In a study comparing two-dimensional (2D),
D-derived M-mode, and RT3DE with magnetic reso-
ance imaging (MRI) measurements of LV volume, mass,
nd EF, MRI end-diastolic LV volume (mean 172  53
l) was underestimated by 2D echocardiography (mean
ifference 54  33 ml) but only slightly by RT3DE (4
29 ml). Similarly, end-systolic volume by MRI (mean 91
53 ml) was underestimated by 2D echocardiography
mean difference 28  28 ml) and by RT3DE (3  18
l). The LV mass was overestimated by M-mode and 2D
chocardiography but slightly underestimated by 3D, with
-mode showing the greatest difference from MRI. Cor-
elation with MRI EF was similar for 2D and 3D (r  0.76
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Manuscript received November 16, 2004; accepted December 1, 2004.nd r  0.74, respectively—values lower than typically
eported for 2D correlations with angiography) (1). Impor-
antly, test-retest variability, which involves repetition of the
ntire acquisition and analysis process, was superior for 3D
han 2D for EF, supporting the role of 3D for serial
valuation. Unfortunately, 10 patients (18%) had to be
xcluded from analysis, 8 for inadequate echocardiography
ecordings. However, the major limitation of 3D echocar-
iography was the analysis time of 630  60 s versus 90 
7 s for 2D echocardiography for volume calculations (1).
or a laboratory performing 10,000 studies per year, this
ould equal 0.8 man-years just analyzing LV volumes,
aking it unlikely that this approach will be generally
mployed until rapid and accurate methods for automated
nalysis are developed. A feasibility study using such an
utomated approach in patients selected for good image
uality and sinus rhythm showed excellent correlation be-
ween the semi-automated method with both manually
efined volumes and MRI volumes, with a slight underes-
imation of both end-diastolic and -systolic volumes but
omparable EFs. Surprisingly, the time for semi-automated
D data analysis was 12  5 min compared with 4  1 min
or manual tracing of the 3D contours (2). Because most
atients do not have optimal images, a great deal more work
eeds to be done in the area of automated calculation of
olumes and mass.
alvular heart disease. In patients with rheumatic mitral
tenosis, it is often difficult to align the 2D scan plane
arallel to the limiting orifice, particularly for inexperi-
nced examiners. To help with this problem, RT3DE
as compared with 2D planimetry, the Doppler pressure
alf-time (PHT), and the proximal acceleration method
PISA) for assessing mitral valve area in comparison with
he Gorlin formula in 80 patients with rheumatic mitral
tenosis. Mean mitral valve area was similar by all
ethods (PHT: 1.28 cm2; 2D: 1.39 cm2; PISA: 1.24
m2; RT3DE: 1.26 cm2; and the Gorlin method: 1.30
m2). However, the agreement of the mitral valve area by
D echocardiography and the Gorlin formula was better
y Bland-Altman analysis than with any of the other
ethods. A recording and analysis time for RT3DE of 23
7 min was observed in a subgroup of 20 patients (3).
Thus, although data are beginning to appear supporting
he value of RT3DE in a variety of clinical settings, the
nalysis time to this point is prohibitive beyond the research
nvironment.
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issue Doppler, strain rate, and strain imaging. Tissue
oppler myocardial velocities have been suggested to be an
bjective quantitative method for assessing myocardial func-
ion. However, both systolic (Sm) and early diastolic (Em)
issue velocities have been shown to be load-dependent.
onversely, myocardial acceleration during isovolumic con-
raction has been shown to be an accurate measure of both
ight and left ventricular contractile function that is unaf-
ected by changes in preload and afterload (4,5). In a
ollow-up experimental study, peak acceleration during
sovolumic relaxation was examined as a load-independent
easure of diastolic function. Peak septal acceleration dur-
ng isovolumic relaxation correlated with both pressure-
erived peak negative dP/dt (r  0.80) and tau (r 
0.87) but not with left atrial (LA) pressure. However,
eak acceleration during the diastolic filling period did
orrelate (r  0.81) with mean LA pressure. Peak lateral
all acceleration also correlated withdP/dtmin and tau but
ess closely than septal acceleration (6).
Although the ability to measure regional function is a
otentially powerful tool, these measurements are not sim-
le, and the results can be complex to interpret. For
xample, in a study to determine normal, age-adjusted
alues for longitudinal strain for individual walls (anterior,
osterior, medial, and lateral) and segments (apical, mid,
nd basal), there was a general velocity gradient from base to
pex for both the systolic (S) wave and the diastolic E and
waves. Both the S- and E-wave velocities (cm/s) de-
reased with age, whereas the A-wave velocity increased.
train rate was not age- or gender-dependent. However,
train data showed inconsistencies with a base-to-apex
radient for the septum and an apex-to-base gradient for the
nterior wall. This is in contrast to MRI data that show that
ongitudinal strain increases from 15% at the base to 19% at
he apex. The difference in the echocardiography results was
xplained by the high sensitivity of strain measurements to
isalignment of the insonation angle relative to the true
all orientation; however, when such findings occur in
elected normals, they highlight the care that must be taken
n acquisition and interpretation of strain data (7).
The mitral E/E= ratio has been suggested as an estimate
f LV filling pressure in selected subsets of patients. In a
tudy comparing the accuracy of this ratio in predicting LV
nd-diastolic pressure in primary mitral regurgitation (pro-
apse and flail leaflets) and secondary mitral regurgitation
dilated and ischemic cardiomyopathy), it was demonstrated
hat while the E/E= ratio showed a reasonable correlation
ith LV end-diastolic pressure in patients with secondary
itral regurgitation (r  0.61), there was no relationship in
atients with primary mitral regurgitation and preserved LV
unction (8).
Several small studies have reported that tissue Doppler
ecording of mitral annular velocity can distinguish between
onstrictive pericarditis and restrictive myopathies. These ibservations were confirmed in two larger studies (9,10) of
atients with constrictive pericarditis and various control
roups. In one study, an E= velocity of 8 cm/s differenti-
ted patients with constriction from those with amyloid or
estrictive cardiomyopathy with a sensitivity of 95% and a
pecificity of 96% (9). In the second study, annular velocities
rom the septal and lateral regions were normal (8 cm/s)
n 45 patients (88.9%) with constrictive pericarditis and
ecreased in one or both regions in five patients (three
atients with reduced LV function and two patients with
xtensive mitral annular calcification). In patients with
estrictive myopathy, 8 of 11 (72.7%) had reduced E=
elocities, whereas 3 patients had normal E= velocities at one
r both corners of the mitral annulus (10).
yocardial contrast echocardiography (MCE). BASIC
CIENCE. Changes in myocardial perfusion after therapeu-
ic interventions have been difficult to assess because of the
mall size of the vessels of interest, which generally cannot
e resolved by angiography, and the difficulty of performing
iopsies of the target areas in clinical studies. As a result,
CE is increasingly used to assess myocardial perfusion in
he experimental assessment of therapies designed to limit
nfarct size and restore function after infarction.
NFARCT SIZE LIMITATION. P-selectin immunoneutraliza-
ion: it is recognized that leukocytes can induce microvas-
ular damage in the reperfused myocardium. P-selectin is
he key molecule responsible for the recruitment of neutro-
hils in areas of inflammation and adhesion of platelets to
eutrophils. In an ischemia reperfusion model, it was
emonstrated that after 120 min of reperfusion, the replen-
shment parameters A (capillary volume),  (myocardial
lood velocity), and A   (myocardial blood flow) were
igher in the risk area and that the infarct size was smaller
n animals after immunoneutralization of P-selectin than in
ontrols, with an associated reduction in the extent of
eutrophil-mediated inflammation (11).
LYCOPROTEIN INHIBITION. Platelets play a major role in
he dissociation of epicardial artery recanalization and tissue
evel perfusion, the “no reflow phenomenon.” In a canine
odel of acute infarction, glycoprotein IIb/IIIa inhibition
y tirofiban was directly demonstrated to improve myocar-
ial perfusion in the infarct zone by both quantitative MCE
nd fluorescent microspheres, early after reperfusion inde-
endent of epicardial patency. Infarct size was also signifi-
antly reduced in glycoprotein IIb/IIIa inhibition-treated
ogs versus control animals (12).
ONE MARROW CELL TRANSPLANTATION. Bone marrow
ell transplantation into the heart has been shown to induce
ngiogenesis. Bone marrow cell transplantation at one
onth after left anterior descending coronary artery ligation
as shown to increase capillary density in the transplant
rea. Wall thickening in the transplant area was also
ncreased. Myocardial contrast intensity measured as acous-
t
(
G
b
T
t
c
o
m
t
g
m
t
i
r
i
b
n
I
m
p
s
b
t
c
S
a
p
p
T
r
i
p
a
m
a
e
c
u
d
c
c
T
C
t
s
t
o
c
v
w
s
a
u
l
a
s
e
p
M
t
c
a
e
i
s
s
p
i
H
i
d
e
3
o
s
d
d
b
v
o
v
A
a
p
i
w
s
a
q
s
a
r
C
h
s
t
c
b
w
p
a
V
A
s
s
p
r
450 Weyman JACC Vol. 45, No. 3, 2005
Year in Echocardiography February 1, 2005:448–55ic units correlated linearly with capillary density (r  0.92)
13).
ENE THERAPY. Enhanced gene transfection has previously
een demonstrated using ultrasound bubble destruction.
his is presumed to be due to cavitation of microbubbles
hat transiently perforate cell membranes or disrupt the
apillary wall to allow delivery of bioactive agents into cells
r interstitial space. Whereas transfection of an adenovirus-
ediated reporter gene has previously been observed after
ransthoracic insonation, the transfection of a functional
ene with a naked plasmid in combination with ultrasound
icrobubble insonation has not been demonstrated. Hepa-
ocyte growth factor (HGF) prevents myocyte death result-
ng from oxidative stress and myocyte apoptosis during
eperfusion injury. The HGF transfection before myocardial
schemia attenuates reperfusion injury, whereas transfection
y direct intramyocardial injection immediately after coro-
ary ligation induces angiogenesis in infarcted myocardium.
n a rat model of myocardial infarction (MI), ultrasound
icrobubble insonation was combined with naked HGF
lasmid injected into the LV chamber, and HGF was
uccessfully transferred into the myocardium as evidenced
y significant expression of HGF protein at seven days. In
reated animals, infarct size was decreased by 60% versus
ontrol animals. Subsequent remodeling was also decreased.
carring was much smaller, capillaries in the myocardium
djacent to the infracted areas were increased, and inotro-
hic reserve for sympathetic stimulation by isuprel was
reserved (14).
RANSPLANT REJECTION. The detection of acute transplant
ejection currently requires endomyocardial biopsy, which is
nvasive and can yield false positives in patients with focal or
atchy rejection. The microbubbles used for MCE are
dhesive to and phagocytosed by leukocytes including
acrophages. In an experimental study of isograft and
llograft rejection, myocardial signal intensity (in gray lev-
ls) obtained after a 10-min period to allow microbubble
ontrast interaction demonstrated a clear gradient between
ntreated allografts (12  2), allografts treated with low-
ose cyclosporine (9  5), allografts treated with high-dose
yclosporine (6  3), and isografts (2  1). These changes
orresponded to similar changes in macrophage and
-lymphocyte counts (15).
linical studies. DETERMINATION OF LV FUNCTION. In-
ravenous echocardiographic contrast agents have been
hown to enhance visualization of the LV blood pool and
hereby improve endocardial definition and the assessment
f regional and global LV function. In a study of 110
onsecutive patients, echocardiography assessment of LV
olume and EF with and without contrast were compared
ith MRI values. Contrast increased the feasibility for
ingle-plane and biplane volume analysis from 87% to 100%
nd 79% to 95%, respectively. Echocardiography volumes
nderestimated MRI values, but the underestimation was
ess using contrast (16). In a second study, use of contrast dgents in intensive care unit patients was demonstrated to
alvage 51% of previously non-diagnostic transthoracic
chocardiograms, a significant proportion of which were in
ostoperative patients (17).
YOCARDIAL PERFUSION-REST STUDIES. Assessment of
he severity of coronary stenosis: Although contrast echo-
ardiography is widely reported to be a reliable method to
ssess myocardial perfusion, a consistent protocol has yet to
merge. In a study comparing intermittent high mechanical
ndex and real-time low mechanical index imaging, it was
hown that low mechanical index imaging has a lower
ensitivity for single-photon emission computed tomogra-
hy (SPECT)-defined perfusion defects than high mechan-
cal index imaging for a variety of technical reasons (18).
owever, in other studies, low mechanical index contrast
maging was reported to differentiate degrees of left anterior
escending coronary artery obstruction (none, mild to mod-
rate, moderate to severe, and total occlusion) in a group of
5 patients undergoing coronary angiography (19). In an-
ther study of patients with acute MI, qualitative MCE was
ensitive but not specific for the detection of perfusion
efects, whereas quantitative MCE showed a significant
ifference between blood flow values (  A) for Throm-
olysis In Myocardial Infarction (TIMI) flow grade 0 to 2
ersus TIMI flow grade 3. Although these reports and
thers (20,21) show roughly similar results, the absolute
alues for  and   A were quite different (Table 1).
SSESSMENT OF COLLATERAL FLOW. Collateral blood flow
fter acute MI can sustain myocardial viability despite
ersistent occlusion of the infarct-related artery. Low power
ntravenous MCE at baseline and with dipyridamole stress
as used to assess collateral flow in 20 patients with akinetic
egments after acute MI who underwent thrombolysis, had
persistent occluded infarct-related artery, and subse-
uently underwent revascularization. Thirty-two percent of
egments in the territory of the infarct-related artery were
kinetic. Of the akinetic segments, 36% showed contractile
eserve with low-dose dobutamine after revascularization.
ontractile reserve was present in 24 of 29 segments with
omogeneous contrast opacification and absent in 60 of 73
egments (82%) with reduced or absent opacification. All
hree quantitative myocardial contrast parameters (peak
ontrast intensity [A], bubble velocity [], and myocardial
lood flow [A  ]) were significantly higher in segments
ith contractile reserve. These results are similar to those
reviously reported for patients with chronically occluded
rteries beyond the acute phase of acute MI (22).
ARIABILITY IN QUANTITATIVE ASSESSMENT OF FLOW.
lthough quantitative MCE has been used to assess perfu-
ion, absolute values for A, , and A   differ between
tudies and with method of data acquisition, even in
atients with normal flow. Table 1 compares the values
eported for A, , and A   from several of the studies
iscussed earlier for control flow in normal vessels. Al-
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February 1, 2005:448–55 Year in Echocardiographyhough the reason for all of these differences is unclear, in
eneral, absolute values for  are significantly lower during
ow compared with high MI imaging. Several reasons have
een suggested for this difference, including: 1) alteration of
he input function as a result of excessive destruction of
ubbles in the LV cavity as a result of multiple flash frames;
) microbubble destruction that may also occur because of
igh frame rates despite low MI; or 3) errors that may occur
rom differences in dynamic range, incorrect curve fitting,
nd noise (23). Despite these differences, values for  and A
 reserve appear almost identical. This suggests that the
aseline quantitative values may not be comparable between
tudies and that patients and some form of stress may be
equired to determine changes in flow reserve.
xercise echocardiography. OUTCOME IN PATIENTS RE-
ERRED FOR DYSPNEA. The results of exercise echocardi-
graphy in patients referred for dyspnea were examined in a
roup of 443 patients. Compared with patients referred for
hest pain, patients with dyspnea alone were older, predom-
nantly men, and had a lower workload, lower EF, more
revious infarcts, and abnormal electrocardiograms. Patients
ith both symptoms were similar to those with dyspnea but
ad more previous revascularizations. Exercise echocardiog-
aphy showed ischemia in 42% of patients with dyspnea,
9% with chest pain, and 58% with both symptoms. During
mean of 3.1  1.8 years of follow-up, cardiac death (5.2%
s. 0.9%) and non-fatal MI (4.7% vs. 2.0%) occurred more
ften in patients with dyspnea. In patients with dyspnea,
ndependent predictors of events were previous MI, male
ender, EF, and increased wall motion score with exercise
ut not chest pain. Patients with lung disease precluding
atisfactory echocardiographic images or with recognized
oncardiac causes for dyspnea were excluded, and thus most
atients in the study had a cardiac cause for dyspnea (24).
REDICTION OF PREOPERATIVE RISK IN PATIENTS WITH
UBMAXIMAL EXERCISE TESTS. Dobutamine stress echo-
ardiography (DSE) is widely used in the preoperative
valuation of ischemic risk in patients with known or
uspected coronary disease. The absence of ischemia on
aximal stress tests is associated with excellent outcomes.
owever, despite the use of high-dose dobutamine and
tropine, it is not always possible to reach the goal of 85%
ge-adjusted heart rate. Perioperative MI was reported to
ccur more frequently (9.4%) in patients with positive tests
either maximal or submaximal), but with equal frequency
n patients with maximal or submaximal tests (submaximal
able 1. Comparison of Resting Quantitative MCE Values With
Coronary Bloo
Flow
eltier et al. (20) Low MI 50% stensos
awson et al. (18) Low MI Normal
High MI Normal
oir et al. (18,21) High MI Normal
CE  myocardial contrast echocardiography; MI  myocardial infarction.74% of maximum despite completing the entire dobut- dmine atropine protocol), 6 of 335 (1.8%) versus 1 of 62
1.6%), respectively. The negative predictive value was 98%,
ith events occurring exclusively in patients with resting
all motion abnormalities (25).
SE OF STRESS TESTING TO PREDICT PERIOPERATIVE
VENTS. Despite the data suggesting that preoperative
tress testing is a potent indicator of postoperative cardiac
vents, this has not been proven in randomized trials. A
mall prospective, randomized study designed to test the
alidity of American Heart Association/American College
f Cardiology guidelines for preoperative stress testing
efore noncardiac (vascular) surgery showed that preopera-
ive stress testing (DSE) offers no incremental value for
etermining postoperative adverse cardiac outcomes. As the
uthors note, larger randomized trials are needed to confirm
his finding (26).
ELATIONSHIP OF TEST PERFORMANCE TO TRANSMURAL
XTENT OF SCAR. Dobutamine stress echocardiography and
hallium SPECT remain the most widely available tests for
he detection of myocardial viability. Thallium SPECT has
een shown in a number of studies to be more sensitive,
hereas DSE is more specific. In a complex study of
atients with previous MI, the relationship of the transmu-
al extent of scar by contrast-enhanced MRI was correlated
ith resting wall motion and estimates of viability by
hallium SPECT and DSE. Over 50% of segments showed
ome residual contraction despite the presence of the trans-
ural extent of scar from 25% to 75% of wall thickness.
isagreements in the assessment of viability were related to
reater extent of the transmural extent of scar in the
egments viable by thallium but not by DSE. These data in
hronic ischemia differ significantly from early dog studies
f acute infarction that demonstrated loss of transmural
hickening, with a transmural extent of infarction of 20%
27). Unfortunately, because contrast-enhanced MRI de-
nes necrosis and not viability and because recovery of
unction was not demonstrated, viability can only be in-
erred (28).
XERCISE TESTING IN MITRAL STENOSIS. In patients with
itral stenosis, there is frequently a discrepancy between
itral valve area and New York Heart Association func-
ional class, particularly after mitral commisurotomy. Pre-
ious studies have used DSE to identify patients with mitral
tenosis who have an important increase in pulmonary artery
ressure with exercise; these studies have shown that re-
mal Coronary Flow
 A A  
0.27 (0.07) 10.1 (1.4) 2.7 (0.8)
0.40 (0.16) 25 (12)
0.71 (0.25) 38 (16)
3.8 (3.2) 12.0 (3.1) 42.8 (36.2)Nor
d
isuced atrial (net) compliance is responsible for pulmonary
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Year in Echocardiography February 1, 2005:448–55ypertension in patients with apparently mild mitral steno-
is by the pressure half time method. In a study of 53
atients with mitral stenosis, 29 (55%) presented with
linical events (16 hospitalizations, 7 cases of acute pulmo-
ary edema, and 6 symptomatic supraventricular arrhyth-
ias) during a mean 60.5  11 months of follow-up.
hirty-one patients had a previous commisurotomy. Mul-
ivariate analysis showed both mitral valve area and a mean
itral gradient at peak exercise of 18 mm Hg to be
ignificant predictors of future events. However, in patients
ith a mitral valve area 1.0 cm2, peak gradient 18 mm
g best predicted outcome (sensitivity 90%, specificity 87%,
nd accuracy 90%). Patients with any other significant
alvular disease or more than mild mitral regurgitation or
ricuspid regurgitation were excluded, restricting the appli-
ation of these findings. In addition no follow-up echocar-
iographic or clinical data (change in New York Heart
ssociation functional class) are reported so that it is un-
lear whether or not simple progression of clinical or
chocardiography-Doppler areas or gradients might also
ave predicted future events. Despite these limitations, the
tudy confirms the potential of DSE to identify selected
atients with moderate mitral stenosis who are at increased
isk for complications (29).
ntracardiac echocardiography. The use of intracardiac
chocardiography to monitor transcardiac interventions
ontinues to expand. In many institutions, intracardiac
chocardiography has replaced transesophageal monitoring
f device closure of atrial septal defects, patent foramen
vale, and a variety other procedures including balloon
alvuloplasty, ventricular tachycardia ablation (30), and coil
blation of pulmonary A-V fistulae (31,32). Intracardiac
chocardiography has several advantages over transesopha-
eal echocardiography: it eliminates the need for general
nesthesia, thus allowing greater flexibility in procedure
cheduling. It provides direct access to intracardiac struc-
ures by the interventionalist and thus allows him to answer
is own questions and eliminates the need for an echocar-
iographer. The technique provides accurate measurement
f the fossa ovalis, obviating the need for balloon sizing that
an itself affect the size of the defect (33). Procedure time is
o different than that using transesophageal echocardiogra-
hy (33). Although the catheters are expensive, the overall
ost is similar to that of transesophageal echocardiography
hen anesthesia and echocardiographic time are considered.
Intercardiac echocardiography is used increasingly to
onitor ablation procedures for atrial fibrillation (AF). It is
ecognized that thrombus formation is a risk associated with
hese procedures. In a study of 232 patients with AF
ndergoing ablation procedures, LA thrombus (n 30) was
bserved in 24 patients (10.3%). Thrombi measured 12.9 
1.1 mm (length) and 2.2  1.3 mm (width) and in each
ase were attached to the sheath or mapping catheter. Most
hrombi were eliminated from the LA by withdrawing the
heath and catheter into the right atrium (RA); however,
wo became stuck in the interatrial septum. Patients who developed thrombi had an increased LA diameter, sponta-
eous echocardiography contrast, and a history of chronic
F. Multivariate analysis showed spontaneous echocardi-
graphy contrast to be the most important determinant of
A thrombus formation. No patient with LA thrombus
eveloped clinical thromboembolic complications (34).
oppler studies. EFFECTS OF LA PRESSURE ON THE AGE-
ELATED CHANGE IN TRANSMITRAL FLOW. Age-related
hanges in the pattern of LV filling (prolongation of the
sovolumic relaxation time, reduction in the early diastolic
E] wave, a more gradual deceleration of early filling
deceleration time], and an augmentation of the atrial
omponent of the filling wave [A]) have been repeatedly
ocumented. It has been suggested that these age-associated
hanges in filling dynamics result primarily from a slowing
f the rate of LV pressure decline manifest by a prolonga-
ion of the time constant of isovolumic pressure decay ().
owever, a recent combined echo-Doppler and MRI study
f normals of varying age failed to show a decline in LV
ressure decay during isovolumic relaxation and suggested
hat age may exert its effect on E-wave velocity and
sovolumic relaxation time through a reduction in early LA
ressure. Thus, the alteration in LV filling patterns with age
ay be more complex than currently appreciated and may
e due in part to a reduced atrial contribution to the early
iastolic pressure gradient (35).
Several recent studies reported that the time interval
etween the onset of mitral inflow and mitral annulus
elocity (TE=-E) correlated well with the time constant of
V pressure decay () and was proposed as a new index of
V relaxation (36,37). In a surprising study of 40 patients
ndergoing cardiac catheterization, initially designed to
alidate this ratio, TE=-E showed no correlation with tau
range 31 to 70 ms). In the patient with the highest tau
alue there was simultaneous onset of mitral inflow and
itral annulus velocity (38). This is obviously an area that
eeds further study.
Several confirmatory Doppler studies were also reported,
ncluding: 1) the demonstration that color M-mode E-wave
elocity propagation (Vp), an essentially preload-
ndependent measure, was a better predictor of LV end-
iastolic pressure and pulmonary congestion based on the
/Vp ratio than the E/A ratio (39); 2) color M-mode
ccurately reported ejection interventricular pressure gradi-
nts (40); 3) a restrictive LV filling pattern (E-wave decel-
ration time 130 ms) in patients with acute MI was
ssociated with a lower EF, greater LV dilation, and a
maller decrease in percent wall motion abnormality during
ollow-up than patients without a restrictive pattern. Pa-
ients in whom the restrictive pattern was reversible before
ischarge had better outcome (four-year survival) than those
ho did not (93% vs. 79%) (41); and 4) the value of the peak
ulmonary regurgitant velocity was validated as a measure of
ean pulmonary artery pressure, with improved correlation
hen the right atrial pressure was added to the Bernoulli-
erived value (42).
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REAS OF PARTICULAR CLINICAL INTEREST
ardiac resynchronization therapy (CRT). The duration
f the QRS complex, an indication of an abnormal pattern
f ventricular electrical activation (left bundle-branch block
nd a QRS duration 120 ms), has been the standard
ethod for identifying patients likely to benefit from CRT.
nfortunately between 20% and 30% of patients so identi-
ed fail to respond to CRT, and patients with a normal
RS duration may have important dyssynchrony. Recent
ata have confirmed that mechanical dyssynchrony is not
ecessarily related to electrical dyssynchrony and that the
resence of important mechanical dyssynchrony is a major
redictor of a response to CRT (43). A number of echo-
ardiographic methods have been used to assess asynchrony,
ncluding M-mode recording of the time delay between
eptal and posterior wall motion; 2D analysis of the phase of
V contraction and regional area change; and tissue Dopp-
er, strain, and strain rate imaging which permit the timing
f peak systolic velocity in different regions to be compared
43). To further define this question, the onset of regional
ontraction by tissue Doppler imaging was examined in 49
onsecutive patients undergoing CRT (27 responders and
2 nonresponders). There was a large overlap in individual
alues of QRS duration between responders and nonre-
ponders. However, tissue Doppler imaging-derived indices
f intraventricular and interventricular asynchrony accu-
ately predicted positive LV remodeling, and the sum of
hese variables predicted responders with sensitivity, speci-
city, and accuracy of 96%, 77%, and 88%, respectively (44).
n another study comparing electrocardiographic and tissue
oppler imaging estimates of dyssynchrony, severe dyssyn-
hrony was observed in 27% of patients with a narrow QRS
omplex (120 ms), in 60% of patients with moderate
lectrocardiographic dyssynchrony (QRS 120 to 150 ms),
nd in 70% of patients with wide QRS complexes (45).
hese and other studies (46,47) continue to show the lack of
eliability of electrocardiographic criteria for the detection of
yssynchrony relative to the direct measurement of mechan-
cal activity.
In a study examining the regional distribution of strain in
he LV immediately before and a day after the onset of
RT, it was demonstrated that CRT patients at baseline
ad a 106  74 ms delay between contraction at the
apillary muscle insertion sites which shortened to 39  43
s after CRT and was significantly correlated with reduc-
ion in mitral regurgitant fraction (48). This suggests that
mproved coordination of mechanical activation of the
apillary muscle insertion sites may reduce abnormal teth-
ring and be responsible for the immediate decrease in
itral regurgitation. This does not exclude the effect of
ncreasing dP/dt and closure forces as previously described
nd underscores the complex forces effecting mitral valve
losure (49). (elationship of aortic atherosclerosis and stroke. A
umber of studies have reported an association between
ortic atherosclerosis recorded by transesophageal echocar-
iography and increased cardiovascular and stroke morbid-
ty and mortality. However, these studies were generally
ased on highly selected transesophageal echocardiography
atients, most with previous strokes, and variable adjust-
ent for the effects of age and other comorbid conditions.
n a prospective study of a group of 579 patients (mean age
6.9  13.3 years) from the Stroke Prevention: Assessment
f Risk in a Community (SPARC) study, the relationship
etween simple and complex (4 mm thick or mobile
ebris) atherosclerotic plaque and vascular events during
ollow-up (mean 5.0 years) was studied. Simple plaques
ere identified in 253 (43.7%) and complex plaques in 44
7.6%) persons. By univariate analysis, atherosclerosis grade
as associated with cardiac and cerebrovascular events;
owever, after adjustment for age, gender, and other risk
actors, there was no significant relationship between either
ype of atherosclerosis and cardiac or cerebrovascular events.
everal atherosclerotic risk factors (age, male gender, higher
ulse pressure, and diabetes) were significant independent
redictors of cardiac events. Predictors of cerebrovascular
vents included age, previous MI, and AF (50). Although a
imited number of patients with complex atherosclerosis
ere studied and the mortality in this group was only
ne-half that of the local population, the data prompt a
eevaluation of the association between aortic atherosclero-
is and cardiovascular morbidity and mortality.
A. The LA remains an area of considerable investigation
ecause of the continuing interest in ablation therapy for
F and the recognized role of atrial size as a marker of di-
stolic function in patients without primary mitral valve
isease. In patients with acute MI, LA volume 32 ml/m2
etermined within the first 48 h after infarction was
onfirmed to be an independent predictor of five-year
ortality and to provide incremental prognostic informa-
ion to clinical (age, diabetes) and echocardiographic data
LV EF) (51,52).
The LA is the source of cardiac emboli in 90% of
atients with nonrheumatic AF in whom an intracardiac
hrombus has been visualized. Although warfarin anticoag-
lation is the standard method of prevention, many patients
ith AF are unable to take warfarin. To treat these patients,
percutaneous LA appendage transcatheter occlusion de-
ice (PLAATO) has recently been introduced to exclude
he LA appendage from the rest of the circulation. How-
ver, the impact of long-term deployment of the device on
djacent structures is unknown. In 11 patients who com-
leted six months of follow-up, the device appeared stable
ith minimal residual flow around PLAATO similar to that
een at baseline. The PLAATO caused no change in the
ize of the left pulmonary vein, transmitral flow velocities,
A size, or mitral regurgitation compared with baseline
53).
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n summary, the number and complexity of echocardio-
raphic techniques continue to grow, with the result that
any methods are proposed to answer similar questions
ach with positive but generally imperfect results. Because
ime and expense preclude the application of multiple
ethods to the same question, further efforts must be made
o standardize approaches and identify situations in which a
articular method is most appropriate.
Given that MRI is the gold standard to which echocar-
iography is compared in many of these studies, it is often
uestioned whether MRI will eventually replace echocardi-
graphy for most applications. The answer is in the wheels.
hen the first MRI machine is seen being wheeled down
he hall and into the patient’s room, echocardiographers
hould be concerned, but until then the flexibility, portabil-
ty, and requisite clinical accuracy will cause echocardiogra-
hy to continue to grow for the foreseeable future.
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